22
Participants
Start Date
October 31, 1998
Primary Completion Date
November 30, 2002
Study Completion Date
November 30, 2002
gemcitabine hydrochloride
tipifarnib
San Antonio Cancer Institute, San Antonio
National Cancer Institute (NCI)
NIH
The University of Texas Health Science Center at San Antonio
OTHER